Abstract
This article discusses the development and progress of treatment for Alzheimer's disease. Medical treatments have not changed since the late 1990s and have limited effects. They treat the symptoms patients experience but do not reverse the effects or repair neurological damage caused by Alzheimer's disease. Updated NICE guidance and likely future advances in treatment are also discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 24-6 |
| Number of pages | 3 |
| Journal | Nursing Times |
| Volume | 110 |
| Issue number | 9 |
| Publication status | Published - 1 Feb 2014 |
Keywords
- Medical Sciences--Nurses And Nursing
- Cholinesterase Inhibitors
- Excitatory Amino Acid Antagonists
- Receptors, N-Methyl-D-Aspartate
- Alzheimers disease
- Older people
- Dementia
- Cognitive ability
- Licenses
- Brain research
- Cholinesterase Inhibitors -- adverse effects
- Humans
- Practice Guidelines as Topic
- Excitatory Amino Acid Antagonists -- adverse effects
- Aged
- Alzheimer Disease -- nursing
- Cholinesterase Inhibitors -- administration & dosage
- Alzheimer Disease -- drug therapy
- Receptors, N-Methyl-D-Aspartate -- antagonists & inhibitors
- Excitatory Amino Acid Antagonists -- administration & dosage
Fingerprint
Dive into the research topics of 'Drug treatments for Alzheimer's disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver